Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Baumgarten

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 21, 2021
Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV-infectionNils Postel, Eva Wolf, Annamaria Balogh, et al.
Open Forum Infectious Diseases|September 27, 2017
Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus CoinfectionChristoph Boesecke, Patrick Ingiliz, Florian Berger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individualsMartin Vogel, Emma Page, Christoph Boesecke, et al.
Psychology, Health & Medicine|February 13, 2018
Anxiety, depression, and health-related quality of life in aging people living with HIV compared to diabetes patients and patients with minor health conditions: a longitudinal studyJoram Ronel, Andreas Dinkel, Eva Wolf, et al.
Antiviral Therapy|September 9, 2011
Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life settingThomas Reiberger, Martin Obermeier, Berit A Payer, et al.
Antiviral Therapy|September 30, 2016
Effect of antiviral therapy for HCV on lipid levelsStefan Mauss, Florian Berger, Malte H Wehmeyer, et al.
AIDS (London, England)|August 14, 2013
Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis CBenjamin Krämer, Hans Dieter Nischalke, Christoph Boesecke, et al.
AIDS (London, England)|July 1, 2010
The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infectionHans Dieter Nischalke, Martin Vogel, Stefan Mauss, et al.
HIV Medicine|May 28, 2024
Still trouble with bleeding: Risk factors for HCV transmission in men who have sex with men and behavioural trajectories from 2019 to 2021Axel Jeremias Schmidt, Peter Weatherburn, Haoyi Wang, et al.
Antiviral Therapy|February 28, 2017
Telaprevir-containing triple therapy in acute HCV coinfection: The CHAT StudyChristoph Boesecke, Gurmit K Jagjit Singh, Stefan H-A Scholten, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 21, 2021
Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV-infectionNils Postel, Eva Wolf, Annamaria Balogh, et al.
Open Forum Infectious Diseases|September 27, 2017
Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus CoinfectionChristoph Boesecke, Patrick Ingiliz, Florian Berger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individualsMartin Vogel, Emma Page, Christoph Boesecke, et al.
Psychology, Health & Medicine|February 13, 2018
Anxiety, depression, and health-related quality of life in aging people living with HIV compared to diabetes patients and patients with minor health conditions: a longitudinal studyJoram Ronel, Andreas Dinkel, Eva Wolf, et al.
Antiviral Therapy|September 9, 2011
Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life settingThomas Reiberger, Martin Obermeier, Berit A Payer, et al.
Antiviral Therapy|September 30, 2016
Effect of antiviral therapy for HCV on lipid levelsStefan Mauss, Florian Berger, Malte H Wehmeyer, et al.
AIDS (London, England)|August 14, 2013
Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis CBenjamin Krämer, Hans Dieter Nischalke, Christoph Boesecke, et al.
AIDS (London, England)|July 1, 2010
The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infectionHans Dieter Nischalke, Martin Vogel, Stefan Mauss, et al.
HIV Medicine|May 28, 2024
Still trouble with bleeding: Risk factors for HCV transmission in men who have sex with men and behavioural trajectories from 2019 to 2021Axel Jeremias Schmidt, Peter Weatherburn, Haoyi Wang, et al.
Antiviral Therapy|February 28, 2017
Telaprevir-containing triple therapy in acute HCV coinfection: The CHAT StudyChristoph Boesecke, Gurmit K Jagjit Singh, Stefan H-A Scholten, et al.
Pageof 6